{"ticker": {"uuid": "33ff7aa9-59f4-412f-9ea1-9469c001a779", "symbol": "ZEAL", "name": "Zealand Pharma A/S", "exchange": "VIE", "country": "AT", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Zealand Pharma (CPSE:ZEAL) Stock Stays Reasonable On Earnings Yet Richer On Fair Value", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPX0RRalB0YzNSSnJUNXlXUzBmLVFYSWoyS0tNNFZNVTdhRWs3MktZRFR6NFlFamRHUFNaaHdORWxfRDdId2hURWhoeWJ6QWdDdFd0WURHYU1LeERVUzNxYkQ2T01NanJBOTFtUUNoaXMxb042WER3aGRaUFg3N0l0Snc4YmNwQ05HZENrQUF4ZS1SSGRqSThzdWV1VQ?oc=5", "source_name": "Market source", "published_at": "2026-07-07T07:00:00+00:00", "published_display": "07 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zealand Pharma - Transactions related to share buy-back program (week 26, 2026)", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxQVXdpOXMwQmFJMF9uc1NFeTdCU1d6bFVkTVJVbFlZRWtrUVIxOXFpUzBLc0NnZVRHbEJ4bk1sNzQ0ZFRKa19VdDdUQmZpUXpzblJHRmZZb3p2THhySUpNR3RoZTJvVktDTlpIZU5QcEVxeGFyX3dsb3pKUkxaNkpQdkdOdmJfd3BKUVVCNnVYTmltWHJicV9CVWRTbGt3QlF1aEFHR0IwMWhvNi11bmNDSzVlcHVvTnlGSGV6endfXy1jSHQ5YlE?oc=5", "source_name": "marketscreener.com", "published_at": "2026-06-29T15:00:07+00:00", "published_display": "29 Jun 2026 15:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zealand Pharma - Transactions related to share buy-back program (week 25, 2026)", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxPcGVZMml4REplVEt2c0w4WFkwamJfTjh6N25fam5JSUlHLXU3MEw2Uzg1VXJhU05Nekpwb3V6NU5MRVdMeVZzUk9kWDRFSWc3YXV3eGJJeXJBY0h0bEtLQWRiOFgyTzdaTDIzcUxNMjFQcGp6V2JuN0c4WnB6Y3ZzaDZQTE90NHpiR0cwZ2loUjZLZWtjV1JWU3F1azBUX2ZfdTJPZTA5NlFnZjFmb1VXbjA5NU9CYVhRWHo2MkhNNTBWd2dLWFE?oc=5", "source_name": "marketscreener.com", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "UBS Cuts Price Target on Zealand Pharma", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxONTVod0VxbnE3SzVxTlJka2ROYlpFLVc2QjNMbENaQ2VvLXJEQmJQdXpRYmM5em9jQ1V2WnZJbnhZTk92ajMxdFZ3TUNXSEttWkpTSUxxLXZYbjBjU0VUU2Vma1dDcDIydzJaalczcEpSLXJJb1NKZ0VhREN5Nm5IVFFOdmpPbmRyWmxxZzBIeUFnNTltWmlZ?oc=5", "source_name": "marketscreener.com", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DNB Carnegie trims Zealand Pharma price target to DKK 425 (440), reiterates Buy", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxPMjNYTlYtWU1NcEh1RUQyVGtGMkRDRnlzdkN5MDhrYWp5b2tSdmVKYVVNZkVUN1QxUF83Y0UzOVBGNnVtSjR0VG9JbEtMYTRWV19oc2RiWHhPVUFVcVVCWXdqSGVJT25TZGZET1NRNC1aZUhfbC1ab0kzVEt5dHhLaktoNjF0Ylo4Z05rbDlvWGJHSklRTzVCZGNQWWE3NjVKNDVsanNZaTFVSnlaQjRMUmtzZ0R0NUl2bWQ4Y0ZYekNBNFNhZDh5Mw?oc=5", "source_name": "marketscreener.com", "published_at": "2026-06-10T07:00:00+00:00", "published_display": "10 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why The Narrative Around Zealand Pharma (CPSE:ZEAL) Is Shifting After Target Resets And Trial Updates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxNd1JpWGo2ZnpHQnhPcl9WQlFzN2hFdWJlNHNfRlNFdk1ackdIeXpyNUZWRXQ2dFVyMTY5QjAtMGx1UUJQTzVIcnRZYXlLb0xZMDdoMjMzYTJ5eGg2NEZMLUFfcEg3YVQ0c2dRUmRRZUYtTU1MaVlWRW82Q01QR1RoT1hzMjdLVVlHQjM1QjJrZVExOWJBWFQwQkZGWk9CRVhOUlE?oc=5", "source_name": "Market source", "published_at": "2026-06-08T07:00:00+00:00", "published_display": "08 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Deutsche Bank raises Zealand Pharma price target to DKK 300 (275), reiterates Hold", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxQd1k2dXVCMDFXVC1LaldwTGpLamY1QTNiTUFKSW15REJQbWpXU1lkNmx0bUkzSlNBQXVaVTFVcXNHZWRfUUxZN2psbnVBQ2xaNDNPR0ZzZTV6SFNvNGlDNzgyOS1ZZ2tTT1l5aVc5Y3dBenlIZWdjQ3ZQY243TWgtcWF6QlRXeWU4RndadlRwZS1vclR0ZWV2eE5BNXNRZ2FtVWdfODFUZHdXSHVPSEVVRjVsN1RpTk0tUG16SzlNeW5ONmRnUldTMlhIVnU?oc=5", "source_name": "marketscreener.com", "published_at": "2026-06-03T07:00:00+00:00", "published_display": "03 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zealand Pharma's (CPH:ZEAL) Solid Profits Have Weak Fundamentals", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Analysts Have Made A Financial Statement On Zealand Pharma A/S' (CPH:ZEAL) First-Quarter Report", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5wFBVV95cUxNdHVYeDI0QnNLbnZlS1QyRDNZTWdFakZtOG5NMEwwbGFIMGxHWURXamVhVmZGLTFXUF9hZG5EV1JSVnZGQkNEeVA5UjlDU2JwcnBSek0tQ0hOdHAxNXplZVFoUG5zN1FHTF9aRkQyTVhobGxZZkg2SWFjcS01SGVkdUVPV25OMWtpblRyYlFaekVWanVPZmJLeVpjcU1vSVlobzVhNlJodUVIUnFMQ0hfQk8xUWhFc2ZCR3lRRmZlakNCVDlvQWI2TkNMcWktVG8xWjZuN2RKaXlYSUxqVF9tUW9OTTRZczjSAewBQVVfeXFMT2JkX2JzN0tlWm1SX1R0VU5mclBqOUlMYjdzbmJqSXk2dHUzczloaURHZzBYeW1XY2Mza0cteXF1NFBrMkZEcl8wNG5pNzY0TjNfS1pTX0dQTXVnRjdyRWFVVlRHSExFT2ItdkRSbW1TZ3NqSGpMbXB3VFdEM051Q0EzQVVPMUdjaERySWFtVmgxQmhaX3BUNjBoMUNzMkZjNXpRM1V4dVR1LVpZd0lFX1NXeFg5XzhoNGNYdG5mamRNb3BCMHJhWGp6TUN4eXVqdXlsS3EwOThVTkhXYTlZaktlM1BubHV1SVBCLTk?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zealand Pharma initiates USD 200 million / DKK 1.3 billion share buy-back program", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxQaHVFbWhMZWlFNnVueTlvVXgzZU4yLXRFb2p3M3AwLVRtLXVxYmNFLXV2ZDFWR2JYbHZFVng5Sm5hR1JSRFRxNnBmQUFLNTQzcXhDZHVwSVRzLWhranVrYzl5SHNMY3ZRUlpkT0VhZ19MUGhuTjNMY0h5bDF6SEY0QlNIdEsxYk9oSmNHckRTTnpodzM5d3RBdzczVXdoR3hnV0N3dTZmM2JoanJuZUszdThxZDR3eE5uZE1fZU9wc1Q1eVJXN2ctdHhWMEQ?oc=5", "source_name": "marketscreener.com", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assessing Zealand Pharma (CPSE:ZEAL) Valuation As New Cambridge Research Hub Expands AI Drug Discovery", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxPVWNyUmFQUVBrdEdyYmZQSEtlZHVRZUtQRzYzUl9RVkVVRVp5LS1vQnludno5MG1tTEZNTWd5eGk4T000ZmplRUhQcGliMDVzaXRwSnpJNkI1S0FwQk0tbGJtR2s2bGhCWk5jTEdqRC12enRDTG1rM1hVT3o4WWpka3FZZnBLYXhNMmpidndmSXRmN1FPaXNFbGFsa0YxWjZ6dXV2ekZB?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zealand Pharma (CPSE:ZEAL) Is Up 14.2% After Obesity Drug Petrelintide Hits Phase 2 Goal - Has The Bull Case Changed?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-03-15T07:00:00+00:00", "published_display": "15 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zealand Pharma (ZEAL) Stock Drops 32% After Obesity Drug Trial Misses Targets", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxQMmdHQmxkZ2FVeFFGTWd3R09aS1NyOXppYzU0SThOTjN0WEpIOGhUcFhXREVRVWVFSE9oWm45NkJlc1NyUkZJUHpiaTQ1Yy1xTl93Skl6RklCaWg2TVJnSFNFby1kTGFzRWhzNm9zdWpuMjBpQXh3QVFZVHgwRXhmOWNpRDQ4OU5CdXAzRWl2bW4wSjBPSXJxRXVZM3NEd3Zq?oc=5", "source_name": "CoinCentral", "published_at": "2026-03-06T08:00:00+00:00", "published_display": "06 Mar 2026 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zealand Pharma A/S (CPH:ZEAL) most popular amongst retail investors who own 46% of the shares, institutions hold 38%", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-02-15T08:00:00+00:00", "published_display": "15 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zealand Pharma Slips as KBC Securities Cuts Its Price Target", "summary": "", "url": "https://news.google.com/rss/articles/CBMi-gFBVV95cUxPTlVpSHBJN2k5TmV3eDdld2trRnprR08zazFPcjFRZVV5UHZDWGVpMG9PbzdxZ3p0bFQycXhqX3JGZVpjenZEZ29nZW9WSmZpZTVRWHNYX09ubk9memd6QU02b2FROVF1amt0SDlvZ0lERkxiSWFkeXFZY1ZBckJEMFBwZWtQYUd0Yzd6a2xTRGZ1U0thV3MyRnBRaVJIOW52QlFLQXRyMGd5VlVweTlzNkxyQlZCalRsU2Flbk96djJIem9Zb2JidE1jZHR0RTAzNzZBRlBQb3laanVtQVFXd21LQjBRbHBJRFFtY2Jlc3k0Yjc4VEpPcGtR?oc=5", "source_name": "marketscreener.com", "published_at": "2026-02-05T08:00:00+00:00", "published_display": "05 Feb 2026 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Weakness In Zealand Pharma A/S (CPH:ZEAL) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-01-25T08:00:00+00:00", "published_display": "25 Jan 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assessing Zealand Pharma (CPSE:ZEAL) Valuation After Prolonged Share Price Weakness", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxNTHBnWTRGTDdNX2tRVWRmdnJJUTEtN0ZDenVNVjBOWUpIMDNJSmZEVU53OE41VzdiMzc5RkUtVElNczNxRFRDMTBDYXNwRjZUZjJQTDlrSjA3NkJQREluc1hreFR3bHJhbVotOFZUcEN0QmFCNWxYRDBldDdzRGlrRTJpWGk3ZjA?oc=5", "source_name": "Market source", "published_at": "2026-01-24T08:00:00+00:00", "published_display": "24 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zealand Pharma A/S: Target Price Consensus and Analysts Recommendations | ZEAL | DK0060257814", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxQWjdjRm9DeG53a0h0OVUzY0lYSjc2NmRfUTNDcVpGMGNBcjdwby12clpJMnlDc0JNMjhPQ2ptRVUzMUhPaUxvTENsOUdHZlBjVU5YQTlOeExpMHFNLWZUVFpBaURIZWY5bWF4VWxZMkwzWXgzYmVxdFY4TW1MQnVnaUVZV3AwbUU?oc=5", "source_name": "marketscreener.com", "published_at": "2020-08-18T23:42:09+00:00", "published_display": "18 Aug 2020 23:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zealand Pharma A/S Announces Board Changes", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxQMHlYT21wZ0Vkc2NjMTRHQXdDUHJOZ21vSERMQW9jb3h0bzlNdk5yaXV2Sy1PODFkaEtoVTZ1WWVjZmM5T3UyZlNsc3AwQUlWNmQyM2J6d0x6VDBGdTZidmhycG1jcUQ0QUtjc3VMNmh4THpPQlNkYVVvay1tN2RuTUE5b1FOVjJJOENvUnVBdDc4TDJ0TmpoQndTVjRtSG9mMFUyUnlsTzg1bU9RLTZqMU92MVZoQ0h4dzc2V0xEWms4TlliTVE?oc=5", "source_name": "marketscreener.com", "published_at": "2020-04-03T07:00:00+00:00", "published_display": "03 Apr 2020 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Zealand Pharma (CPSE:ZEAL) Stock Stays Reasonable On Earnings Yet Richer On Fair Value", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPX0RRalB0YzNSSnJUNXlXUzBmLVFYSWoyS0tNNFZNVTdhRWs3MktZRFR6NFlFamRHUFNaaHdORWxfRDdId2hURWhoeWJ6QWdDdFd0WURHYU1LeERVUzNxYkQ2T01NanJBOTFtUUNoaXMxb042WER3aGRaUFg3N0l0Snc4YmNwQ05HZENrQUF4ZS1SSGRqSThzdWV1VQ?oc=5", "source_name": "Market source", "published_at": "2026-07-07T07:00:00+00:00", "published_display": "07 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zealand Pharma - Transactions related to share buy-back program (week 26, 2026)", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxQVXdpOXMwQmFJMF9uc1NFeTdCU1d6bFVkTVJVbFlZRWtrUVIxOXFpUzBLc0NnZVRHbEJ4bk1sNzQ0ZFRKa19VdDdUQmZpUXpzblJHRmZZb3p2THhySUpNR3RoZTJvVktDTlpIZU5QcEVxeGFyX3dsb3pKUkxaNkpQdkdOdmJfd3BKUVVCNnVYTmltWHJicV9CVWRTbGt3QlF1aEFHR0IwMWhvNi11bmNDSzVlcHVvTnlGSGV6endfXy1jSHQ5YlE?oc=5", "source_name": "marketscreener.com", "published_at": "2026-06-29T15:00:07+00:00", "published_display": "29 Jun 2026 15:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zealand Pharma - Transactions related to share buy-back program (week 25, 2026)", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxPcGVZMml4REplVEt2c0w4WFkwamJfTjh6N25fam5JSUlHLXU3MEw2Uzg1VXJhU05Nekpwb3V6NU5MRVdMeVZzUk9kWDRFSWc3YXV3eGJJeXJBY0h0bEtLQWRiOFgyTzdaTDIzcUxNMjFQcGp6V2JuN0c4WnB6Y3ZzaDZQTE90NHpiR0cwZ2loUjZLZWtjV1JWU3F1azBUX2ZfdTJPZTA5NlFnZjFmb1VXbjA5NU9CYVhRWHo2MkhNNTBWd2dLWFE?oc=5", "source_name": "marketscreener.com", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "UBS Cuts Price Target on Zealand Pharma", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxONTVod0VxbnE3SzVxTlJka2ROYlpFLVc2QjNMbENaQ2VvLXJEQmJQdXpRYmM5em9jQ1V2WnZJbnhZTk92ajMxdFZ3TUNXSEttWkpTSUxxLXZYbjBjU0VUU2Vma1dDcDIydzJaalczcEpSLXJJb1NKZ0VhREN5Nm5IVFFOdmpPbmRyWmxxZzBIeUFnNTltWmlZ?oc=5", "source_name": "marketscreener.com", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DNB Carnegie trims Zealand Pharma price target to DKK 425 (440), reiterates Buy", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxPMjNYTlYtWU1NcEh1RUQyVGtGMkRDRnlzdkN5MDhrYWp5b2tSdmVKYVVNZkVUN1QxUF83Y0UzOVBGNnVtSjR0VG9JbEtMYTRWV19oc2RiWHhPVUFVcVVCWXdqSGVJT25TZGZET1NRNC1aZUhfbC1ab0kzVEt5dHhLaktoNjF0Ylo4Z05rbDlvWGJHSklRTzVCZGNQWWE3NjVKNDVsanNZaTFVSnlaQjRMUmtzZ0R0NUl2bWQ4Y0ZYekNBNFNhZDh5Mw?oc=5", "source_name": "marketscreener.com", "published_at": "2026-06-10T07:00:00+00:00", "published_display": "10 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why The Narrative Around Zealand Pharma (CPSE:ZEAL) Is Shifting After Target Resets And Trial Updates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxNd1JpWGo2ZnpHQnhPcl9WQlFzN2hFdWJlNHNfRlNFdk1ackdIeXpyNUZWRXQ2dFVyMTY5QjAtMGx1UUJQTzVIcnRZYXlLb0xZMDdoMjMzYTJ5eGg2NEZMLUFfcEg3YVQ0c2dRUmRRZUYtTU1MaVlWRW82Q01QR1RoT1hzMjdLVVlHQjM1QjJrZVExOWJBWFQwQkZGWk9CRVhOUlE?oc=5", "source_name": "Market source", "published_at": "2026-06-08T07:00:00+00:00", "published_display": "08 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Deutsche Bank raises Zealand Pharma price target to DKK 300 (275), reiterates Hold", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxQd1k2dXVCMDFXVC1LaldwTGpLamY1QTNiTUFKSW15REJQbWpXU1lkNmx0bUkzSlNBQXVaVTFVcXNHZWRfUUxZN2psbnVBQ2xaNDNPR0ZzZTV6SFNvNGlDNzgyOS1ZZ2tTT1l5aVc5Y3dBenlIZWdjQ3ZQY243TWgtcWF6QlRXeWU4RndadlRwZS1vclR0ZWV2eE5BNXNRZ2FtVWdfODFUZHdXSHVPSEVVRjVsN1RpTk0tUG16SzlNeW5ONmRnUldTMlhIVnU?oc=5", "source_name": "marketscreener.com", "published_at": "2026-06-03T07:00:00+00:00", "published_display": "03 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zealand Pharma's (CPH:ZEAL) Solid Profits Have Weak Fundamentals", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Analysts Have Made A Financial Statement On Zealand Pharma A/S' (CPH:ZEAL) First-Quarter Report", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zealand Pharma initiates USD 200 million / DKK 1.3 billion share buy-back program", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxQaHVFbWhMZWlFNnVueTlvVXgzZU4yLXRFb2p3M3AwLVRtLXVxYmNFLXV2ZDFWR2JYbHZFVng5Sm5hR1JSRFRxNnBmQUFLNTQzcXhDZHVwSVRzLWhranVrYzl5SHNMY3ZRUlpkT0VhZ19MUGhuTjNMY0h5bDF6SEY0QlNIdEsxYk9oSmNHckRTTnpodzM5d3RBdzczVXdoR3hnV0N3dTZmM2JoanJuZUszdThxZDR3eE5uZE1fZU9wc1Q1eVJXN2ctdHhWMEQ?oc=5", "source_name": "marketscreener.com", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assessing Zealand Pharma (CPSE:ZEAL) Valuation As New Cambridge Research Hub Expands AI Drug Discovery", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxPVWNyUmFQUVBrdEdyYmZQSEtlZHVRZUtQRzYzUl9RVkVVRVp5LS1vQnludno5MG1tTEZNTWd5eGk4T000ZmplRUhQcGliMDVzaXRwSnpJNkI1S0FwQk0tbGJtR2s2bGhCWk5jTEdqRC12enRDTG1rM1hVT3o4WWpka3FZZnBLYXhNMmpidndmSXRmN1FPaXNFbGFsa0YxWjZ6dXV2ekZB?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zealand Pharma (CPSE:ZEAL) Is Up 14.2% After Obesity Drug Petrelintide Hits Phase 2 Goal - Has The Bull Case Changed?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-03-15T07:00:00+00:00", "published_display": "15 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zealand Pharma (ZEAL) Stock Drops 32% After Obesity Drug Trial Misses Targets", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxQMmdHQmxkZ2FVeFFGTWd3R09aS1NyOXppYzU0SThOTjN0WEpIOGhUcFhXREVRVWVFSE9oWm45NkJlc1NyUkZJUHpiaTQ1Yy1xTl93Skl6RklCaWg2TVJnSFNFby1kTGFzRWhzNm9zdWpuMjBpQXh3QVFZVHgwRXhmOWNpRDQ4OU5CdXAzRWl2bW4wSjBPSXJxRXVZM3NEd3Zq?oc=5", "source_name": "CoinCentral", "published_at": "2026-03-06T08:00:00+00:00", "published_display": "06 Mar 2026 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zealand Pharma A/S (CPH:ZEAL) most popular amongst retail investors who own 46% of the shares, institutions hold 38%", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-02-15T08:00:00+00:00", "published_display": "15 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zealand Pharma Slips as KBC Securities Cuts Its Price Target", "summary": "", "url": "https://news.google.com/rss/articles/CBMi-gFBVV95cUxPTlVpSHBJN2k5TmV3eDdld2trRnprR08zazFPcjFRZVV5UHZDWGVpMG9PbzdxZ3p0bFQycXhqX3JGZVpjenZEZ29nZW9WSmZpZTVRWHNYX09ubk9memd6QU02b2FROVF1amt0SDlvZ0lERkxiSWFkeXFZY1ZBckJEMFBwZWtQYUd0Yzd6a2xTRGZ1U0thV3MyRnBRaVJIOW52QlFLQXRyMGd5VlVweTlzNkxyQlZCalRsU2Flbk96djJIem9Zb2JidE1jZHR0RTAzNzZBRlBQb3laanVtQVFXd21LQjBRbHBJRFFtY2Jlc3k0Yjc4VEpPcGtR?oc=5", "source_name": "marketscreener.com", "published_at": "2026-02-05T08:00:00+00:00", "published_display": "05 Feb 2026 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Weakness In Zealand Pharma A/S (CPH:ZEAL) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-01-25T08:00:00+00:00", "published_display": "25 Jan 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assessing Zealand Pharma (CPSE:ZEAL) Valuation After Prolonged Share Price Weakness", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxNTHBnWTRGTDdNX2tRVWRmdnJJUTEtN0ZDenVNVjBOWUpIMDNJSmZEVU53OE41VzdiMzc5RkUtVElNczNxRFRDMTBDYXNwRjZUZjJQTDlrSjA3NkJQREluc1hreFR3bHJhbVotOFZUcEN0QmFCNWxYRDBldDdzRGlrRTJpWGk3ZjA?oc=5", "source_name": "Market source", "published_at": "2026-01-24T08:00:00+00:00", "published_display": "24 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zealand Pharma A/S: Target Price Consensus and Analysts Recommendations | ZEAL | DK0060257814", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxQWjdjRm9DeG53a0h0OVUzY0lYSjc2NmRfUTNDcVpGMGNBcjdwby12clpJMnlDc0JNMjhPQ2ptRVUzMUhPaUxvTENsOUdHZlBjVU5YQTlOeExpMHFNLWZUVFpBaURIZWY5bWF4VWxZMkwzWXgzYmVxdFY4TW1MQnVnaUVZV3AwbUU?oc=5", "source_name": "marketscreener.com", "published_at": "2020-08-18T23:42:09+00:00", "published_display": "18 Aug 2020 23:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zealand Pharma A/S Announces Board Changes", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxQMHlYT21wZ0Vkc2NjMTRHQXdDUHJOZ21vSERMQW9jb3h0bzlNdk5yaXV2Sy1PODFkaEtoVTZ1WWVjZmM5T3UyZlNsc3AwQUlWNmQyM2J6d0x6VDBGdTZidmhycG1jcUQ0QUtjc3VMNmh4THpPQlNkYVVvay1tN2RuTUE5b1FOVjJJOENvUnVBdDc4TDJ0TmpoQndTVjRtSG9mMFUyUnlsTzg1bU9RLTZqMU92MVZoQ0h4dzc2V0xEWms4TlliTVE?oc=5", "source_name": "marketscreener.com", "published_at": "2020-04-03T07:00:00+00:00", "published_display": "03 Apr 2020 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 79, "total_relevant": 19, "sentiment_summary": {"positive": 4, "negative": 3, "neutral": 12, "score": 51, "total": 19, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 82, "events": [{"event": "general", "label": "Market update", "weight": 6.6, "count": 12}, {"event": "analyst", "label": "Analyst action", "weight": 3.3, "count": 6}, {"event": "earnings", "label": "Earnings", "weight": 0.55, "count": 1}], "positive_events": 4, "negative_events": 3}, "market_context": {"has_market_context": true, "latest_close": 37.75, "latest_week": "2026-07-10", "one_week_move": -6.5, "four_week_move": -4.7, "twelve_week_move": -13.4, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.0, "market_dynamics_buy_signal": false, "relative_strength": null, "fair_value_gap": -7.6, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 48.6957, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-6.5% over one week, -4.7% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 60, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "marketscreener.com", "count": 9}, {"label": "simplywall.st", "count": 5}, {"label": "Market source", "count": 4}, {"label": "CoinCentral", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 19}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 12}, {"label": "Analyst action", "count": 6}, {"label": "Earnings", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "51/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "82/100 classification confidence."}, {"label": "Company focus", "value": "19", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-6.5% over one week, -4.7% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Zealand Pharma (CPSE:ZEAL) Stock Stays Reasonable On Earnings Yet Richer On Fair Value"}], "updated_at": "2026-07-17T22:39:49.448647+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}